Raj Mayur Amin, MD
Orthopedic Surgery · Clovis
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
- Since medical school
- 11 years
- Michigan State University College of Human Medicine, 2015
Offices
4 locations · Community Health Partners · 497 clinicians in this group
Hospitals listed: 757053 · Clovis Community Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Amin’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A167640 · Current
Licensed to practise in California · since 2020 · expires 2028-01-31 · Michigan State University College of Human Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Orthopaedic Surgery - Orthopaedic Surgery
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Clovis Community Medical CenterClovis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (12.1 to 17.7) · 421 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.692, Oct 2024 – Sep 2025
See every measure and the patient survey for Clovis Community Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.7 (12.1 to 17.7) · 421 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.692 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.04 to 1.89) · 1,840 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.86 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 217.06 (167.45 to 266.67) · 84 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 507 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 798 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 336 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 3,771 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 8,649 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,146 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.47 to 5.45) · 1,654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.19 (0.61 to 3.78) · 387 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.7 to 3.66) · 1,578 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.47 (7.08 to 19.87) · 374 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (1.37 to 8.61) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.04) · 405 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.8 (0.23 to 1.38) · 8,198 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 90 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.922 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.449 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.509 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 210 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 58.4 · 556 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18 · 769 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 802 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4 to 7.4) · 421 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.8 to 15.6) · 2,398 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 720 cases | No different | Jan 2024 – Dec 2024 |
What patients said (441 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$213,354
Medicare paid this office $213,354 for 455 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of knee joint, both sides of knee | 49 | $50,818 | $996 |
| Short return visit (20+ min) | 217 | $20,385 | $65 |
| Aspiration and/or injection of fluid from large joint | 153 | $19,198 | $55 |
| New patient visit (45+ min) | 152 | $18,545 | $122 |
| Replacement of thigh bone and hip joint with prosthesis | 15 | $16,736 | $1,046 |
See all 19 services
| Replacement of knee joint, both sides of knee | 49 | $50,818 | $996 |
| Short return visit (20+ min) | 217 | $20,385 | $65 |
| Aspiration and/or injection of fluid from large joint | 153 | $19,198 | $55 |
| New patient visit (45+ min) | 152 | $18,545 | $122 |
| Replacement of thigh bone and hip joint with prosthesis | 15 | $16,736 | $1,046 |
| Return visit (30+ min) | 145 | $16,006 | $89 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 46 | $8,191 | $171 |
| Short return visit | 88 | $5,922 | $40 |
| X-ray of knee, 4 or more views | 113 | $5,789 | $37 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 53 | $5,665 | $86 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 13 | $5,157 | None |
| X-ray of knee, 3 views | 109 | $4,312 | $31 |
| X-ray of hip, 2-3 views | 87 | $3,993 | $36 |
| New patient visit (60+ min) | 21 | $3,604 | $172 |
| Telephone medical discussion with physician, 5-10 minutes | 28 | $1,386 | $43 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 187 | $1,230 | None |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 79 | $1,066 | None |
| X-ray of shoulder, minimum of 2 views | 12 | $518 | $29 |
| X-ray of both hips, minimum of 5 views | 11 | $467 | $42 |
Procedures Medicare counted
| Hip replacement | 13 | More than 55% of doctors who do this |
| Knee replacement | 41 | More than 73% of doctors who do this |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Removal of tissue | 1-10 | None |
Procedures year by year
| Procedure | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 42 | 146 | 311 | 346 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | – | 47 | 80 | 66 |
| Replacement of knee joint, both sides of knee | – | 29 | 72 | 51 |
| Replacement of thigh bone and hip joint with prosthesis | – | 14 | 15 | 16 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
455 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 9% · Women 61% · Also on Medicaid 25% · Health risk score 1.11. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 41% · Coronary heart disease 36% · Chronic kidney disease 27% · Depression 18% · Heart failure 17% · Atrial fibrillation 14% · Cancer 12% · COPD 10% · Stroke 5% · Dementia 4%.
The office billed $712,603, Medicare allowed $281,616 and paid $213,354; for 4,571 services of 47 kinds; $16,935 of it was for drugs given in the office and $196,419 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 455 | 4,571 | 74 | 1.11 | $712,603 | $213,354 |
| 2023 | 435 | 4,107 | 73 | 1.06 | $732,669 | $234,653 |
| 2022 | 291 | 2,317 | 73 | 1.01 | $387,765 | $129,719 |
| 2021 | 103 | 548 | 72 | 1.21 | $89,756 | $23,597 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Replacement of knee joint, both sides of knee | 66 | $74,421 | $1,034 |
| Short return visit (20+ min) | 204 | $20,685 | $69 |
| Aspiration and/or injection of fluid from large joint | 158 | $18,501 | $59 |
| Replacement of thigh bone and hip joint with prosthesis | 14 | $15,504 | $1,034 |
| New patient visit (45+ min) | 108 | $13,963 | $129 |
| Return visit (30+ min) | 92 | $11,156 | $103 |
| X-ray of knee, 4 or more views | 164 | $8,358 | $38 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 52 | $6,886 | $86 |
| X-ray of hip, 2-3 views | 96 | $5,544 | $39 |
| New patient visit (30+ min) | 76 | $5,182 | $68 |
| X-ray of knee, 3 views | 106 | $5,141 | $34 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 29 | $5,051 | $174 |
| Short return visit | 81 | $4,777 | $45 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 15 | $3,620 | None |
| New patient visit (60+ min) | 20 | $3,450 | $172 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 102 | $1,425 | None |
| Telephone medical discussion with physician, 5-10 minutes | 27 | $1,317 | $44 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 181 | $1,271 | None |
| X-ray of thigh bone, minimum 2 views | 17 | $832 | $31 |
2022: 16 services
| Replacement of knee joint, both sides of knee | 27 | $30,256 | $1,043 |
| Replacement of thigh bone and hip joint with prosthesis | 13 | $14,639 | $1,046 |
| Short return visit (20+ min) | 101 | $11,093 | $74 |
| New patient visit (45+ min) | 73 | $9,655 | $132 |
| New patient visit (30+ min) | 100 | $8,780 | $88 |
| Aspiration and/or injection of fluid from large joint | 89 | $8,444 | $58 |
| Return visit (30+ min) | 43 | $4,895 | $100 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 37 | $4,018 | $85 |
| X-ray of knee, 3 views | 66 | $3,850 | $35 |
| X-ray of hip, 2-3 views | 53 | $3,183 | $40 |
| X-ray of knee, 4 or more views | 56 | $3,115 | $39 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 15 | $2,448 | None |
| Telephone medical discussion with physician, 5-10 minutes | 30 | $1,495 | $47 |
| Short return visit | 32 | $1,480 | $44 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 68 | $942 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 105 | $639 | None |
2021: 9 services
| New patient visit (30+ min) | 44 | $3,927 | $89 |
| New patient visit (45+ min) | 28 | $3,604 | $129 |
| Aspiration and/or injection of fluid from large joint | 41 | $2,454 | $58 |
| Short return visit (20+ min) | 17 | $1,446 | $76 |
| X-ray of knee, 3 views | 29 | $1,246 | $35 |
| X-ray of hip, 2-3 views | 15 | $719 | $40 |
| X-ray of knee, 4 or more views | 12 | $629 | $39 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $95 | None |
| Injection, methylprednisolone acetate, 40 mg | 13 | $72 | None |
Medicaid work
$12,271 in 2024
Medicaid paid $12,271 for 114 billed services this clinician did in 2024, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 52 | $12,213 |
| Arthrocentesis and injection of knee joint | 41 | $59 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $0 |
| 2024 | 114 | 3 | 24 | $12,271 |
| 2023 | 34 | 2 | 14 | $3,184 |
| 2022 | 90 | 2 | 14 | $9,758 |
| 2021 | 18 | 1 | 18 | $3,394 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 14 | $3,160 |
| Short return visit (20+ min) | 20 | $24 |
2022
| Clinic visit/encounter, all-inclusive | 52 | $9,758 |
| Short return visit (20+ min) | 38 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 18 | $3,394 |
Drugs they prescribed that Part D paid
$13,084
Pharmacies billed $13,084 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 31% of their Part D prescriptions (122 of 388) in 2024. Above the middle of the specialty; the typical orthopedic surgery clinician is at 31%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
370 generic and fewer than 11 brand-name prescriptions · $13,084 in drug cost · 144 antibiotic prescriptions to 108 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 14 | $8,356 | $522 |
| Oxycodone | 94 | $772 | $6 |
| Naproxen | 71 | $537 | $7 |
| Clindamycin | 37 | $426 | $10 |
| Cephalexin | 41 | $319 | $7 |
See all 7 drugs
| Eliquis | 14 | $8,356 | $522 |
| Oxycodone | 94 | $772 | $6 |
| Naproxen | 71 | $537 | $7 |
| Clindamycin | 37 | $426 | $10 |
| Cephalexin | 41 | $319 | $7 |
| Doxycycline Monohydrate | 11 | $163 | $11 |
| Sulfamethoxazole-Trimethoprim | 28 | $114 | $3 |
Year by year
| 2024 | 388 | 126 | 31% (122) | None | $13,084 |
| 2023 | 229 | 91 | 26% (60) | 7% | $10,145 |
| 2022 | 99 | 47 | 25% (25) | None | $2,983 |
| 2021 | 26 | 22 | None | None | $1,129 |
| 2020 | 23 | 17 | None | 0% | $1,247 |
| 2019 | 26 | 18 | None | None | $546 |
| 2018 | 25 | 22 | 80% (20) | None | $429 |
| 2017 | 21 | 17 | 67% (14) | None | $273 |
| 2016 | 32 | 21 | 53% (17) | None | $2,263 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Eliquis | 12 | $6,320 | $527 |
| Naproxen | 56 | $534 | $10 |
| Oxycodone | 58 | $519 | $9 |
| Diclofenac | 12 | $376 | $31 |
| Clindamycin | 22 | $264 | $12 |
| Doxycycline Monohydrate | 13 | $214 | $16 |
| Sulfamethoxazole-Trimethoprim | 28 | $161 | $6 |
2022: 2 drugs
| Diclofenac | 17 | $1,185 | $70 |
| Oxycodone | 16 | $180 | $11 |
2020: 1 drug
| Diclofenac | 11 | $1,107 | $101 |
2018: 1 drug
| Oxycodone | 14 | $103 | $7 |
2016: 1 drug
| Oxycodone | 15 | $176 | $12 |
Money from drug and device companies
$6,198 in 2025
| 2025 | 11 | 29 | $4,250 | $6,198 |
| 2024 | 5 | 25 | $7,000 | $9,524 |
| 2023 | 4 | 21 | $19,450 | $21,015 |
| 2022 | 4 | 11 | $1,625 | $4,653 |
| 2021 | 3 | 16 | None | $6,708 |
| 2020 | 1 | 1 | None | $5,000 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Think Surgical | Tmini Miniature Robotic System | $4,865 | 2 payments
|
| Cornerstone Medical Associates | None | $545 | 3 payments
|
| Arthrex | None | $276 | 5 payments
|
| Stryker | Mako | $263 | 8 payments
|
| Vertex Pharmaceuticals | Journavx | $77 | 3 payments
|
| Davol | Arista | $43 | 2 payments
|
See all 29 published payments
| Vertex Pharmaceuticals | Meals · 2025-12-15 | Journavx | $26 |
| Arthrex | Meals · 2025-12-13 | None | $29 |
| Arthrex | Meals · 2025-12-13 | None | $29 |
| Arthrex | Meals · 2025-12-13 | None | $29 |
| Arthrex | Meals · 2025-12-13 | None | $29 |
| Cornerstone Medical Associates | Travel · 2025-12-12 | None | $269 |
| Cornerstone Medical Associates | Travel · 2025-12-12 | None | $4 |
| Cornerstone Medical Associates | Travel · 2025-12-11 | None | $271 |
| Arthrex | Travel · 2025-12-11 | None | $161 |
| Pacira Pharmaceuticals | Meals · 2025-09-08 | Zilretta | $24 |
| Heraeus Medical | Meals · 2025-08-13 | Palacos | $15 |
| Amgen | Meals · 2025-08-12 | Krystexxa | $28 |
| Vertex Pharmaceuticals | Meals · 2025-07-28 | Journavx | $24 |
| Stryker | Meals · 2025-06-25 | Mako | $108 |
| Avanos Medical | Meals · 2025-06-24 | Trivisc Sodium Hyaluronate | $15 |
| Vertex Pharmaceuticals | Meals · 2025-06-05 | Journavx | $27 |
| Solventum | Meals · 2025-04-17 | Prevena | $30 |
| Stryker | Meals · 2025-03-26 | Mako | $3 |
| Stryker | Meals · 2025-03-26 | Mako | $18 |
| Stryker | Meals · 2025-03-26 | Mako | $1 |
| Think Surgical | Consulting · 2025-03-12 | Tmini Miniature Robotic System | $4,250 |
| Think Surgical | Travel · 2025-03-12 | Tmini Miniature Robotic System | $615 |
| Stryker | Meals · 2025-03-06 | Mako | $25 |
| Stryker | Meals · 2025-03-06 | Mako | $87 |
| Davol | Meals · 2025-03-06 | Arista | $14 |
| Avanos Medical | Meals · 2025-02-06 | Trivisc Sodium Hyaluronate | $17 |
| Davol | Meals · 2025-01-17 | Arista | $29 |
| Stryker | Meals · 2025-01-08 | Mako | $12 |
| Stryker | Meals · 2025-01-07 | Mako | $8 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $9,524
| Think Surgical | Tmini Miniature Robotic System | $7,471 | 6 payments
|
| Stryker | Mako | $1,603 | 13 payments
|
| Zimmer Biomet Holdings | None | $258 | 3 payments
|
| DePuy Synthes Sales | None | $175 | 2 payments
|
| Vertex Pharmaceuticals | None | $18 | 1 payment
|
2023: $21,015
| Think Surgical | Tmini Miniature Robotic System | $20,564 | 10 payments
|
| Stryker | Mako | $410 | 9 payments
|
| Pacira Pharmaceuticals | Exparel | $22 | 1 payment
|
| Bioventus | Durolane | $19 | 1 payment
|
2022: $4,653
| Think Surgical | Tsolution One Surgical System | $3,432 | 3 payments
|
| Stryker | Mako | $1,122 | 6 payments
|
| Zimmer Biomet Holdings | None | $67 | 1 payment
|
| Ethicon US | Dermabond Prineo | $32 | 1 payment
|
2021: $6,708
| Smith+Nephew | None | $5,000 | 1 payment
|
| Stryker | Mako | $1,295 | 10 payments
|
| Zimmer Biomet Holdings | Rosa-Knee | $413 | 5 payments
|
2020: $5,000
| Smith+Nephew | None | $5,000 | 1 payment
|
Professional record
- NPI
- 1942689393
- Licence
- CA A167640California A167640: Current · expires 2028-01-31
- Trained
- Michigan State University College of Human Medicine, 2015 · 11 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207XS0114X (207XS0114X); Orthopedic surgery (207X00000X); Federal specialty code 207XX0005X (207XX0005X); Federal specialty code 207XX0801X (207XX0801X)
- Mailing address
- 2625 E Divisadero St, Fresno, CA, 93721
- NPI first listed
- 2015-05-19
- NPI last updated
- 2024-03-07
- NPI record certified
- 2024-03-07
This is when the NPI record was last certified, not a medical board exam.